Evening-versus morning-dosing drug therapy for chronic kidney disease patients with hypertension: A systematic review

Kidney and Blood Pressure Research

Volumn 39, Issue 5, 2014, Pages 427-440

  Liu, Xing ^a   Liu, Xinyao ^a   Huang, Wei ^a   Leo, Sunnar ^a   Li, Ying ^a   Liu, Meilin ^b   Yuan, Hong ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

Chronic kidney disease; Chronotherapy; Hypertension

Indexed keywords

ANTIHYPERTENSIVE AGENT;

ARTICLE; BIBLIOGRAPHIC DATABASE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE REGULATION; CARDIAC PATIENT; CARDIOVASCULAR MORTALITY; CHRONIC KIDNEY DISEASE; COMPARATIVE STUDY; DIASTOLIC BLOOD PRESSURE; DRUG DOSE COMPARISON; DRUG EFFECT; EVENING DOSAGE; HEART DEATH; HUMAN; HYPERTENSION; META ANALYSIS; MORNING DOSAGE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; TREATMENT DURATION; BLOOD PRESSURE; CHRONOTHERAPY; CONTROLLED CLINICAL TRIAL (TOPIC); DRUG EFFECTS; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; RENAL INSUFFICIENCY, CHRONIC;

ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CONTROLLED CLINICAL TRIALS AS TOPIC; DRUG CHRONOTHERAPY; HUMANS; HYPERTENSION; RENAL INSUFFICIENCY, CHRONIC;

EID: 84917729198     PISSN: 14204096     EISSN: 14230143     Source Type: Journal    
DOI: 10.1159/000368456     Document Type: Article

References (48)

1. Minutolo R, Agarwal R, Borrelli S: Prognostic role of ambulatory blood pressure measurement in patients with nondialysis chronic kidney disease. Arch Intern Med 2011;171:1090-1098
2. Torffvit O: The effect of achieving a systolic blood pressure of 140 mmhg. A prospective study of ambulatory measurements in type 2 diabetic patients with nephropathy. J Diab Complications 2012;26:540-545
3. Hermida RC, Smolensky MH, Ayala DE: 2013 ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-Associated risk, and attainment of therapeutic goals. Chronobiol Int 2013;30:355-410
4. Agarwal R, Andersen MJ: Prognostic importance of ambulatory blood pressure recordings in patients with chronic kidney disease. Kidney Int 2006;69:1175-1180
5. Gabbai FB, Rahman M, Hu B: Relationship between ambulatory BP and clinical outcomes in patients with hypertensive CKD. Clin J Am Soc Nephrol 2012;7:1770-1776
6. Ivanovic BA, Tadic MV, Celic VP: To dip or not to dip? The unique relationship between different blood pressure patterns and cardiac function and structure. J Hum Hypertens 2013;2013:62-70
7. Fujimura A: Chronotherapy-present and future. Nihon Rinsho 2013;71:2097-2101
8. Moher D, Cook DJ, Eastwood S: Improving the quality of reports of meta-Analyses of randomised controlled trials: The QUOROM statement. Quality of Reporting of Meta-Analyses. Lancet 1999;354:1896-1900
9. Green S: Cochrane handbook for systematic reviews of interventions version 5.1. 0 [updated March 2011]. The Cochrane Collaboration, 2011
10. Brozek J, Oxman AD, Schünemann HJ: GRADEpro (computer program) version 3.2 for windows. 2012
11. Mai JZ, Li H, Fang JQ, Liu XQ, Rao XX: Estimation of fail-safe number in meta-Analysis. J Evidence Based Med 2006;6:297-303
12. Shen Y, Lu X: Clinical study of taking medicine at bedtime for CKD patients to reduce cardiovascular events. Mod Instrum Med Treatment 2014;20: 89-91
13. Hermida RC, Ayala DE, Mojon A, Fernandez JR: Bedtime dosing of antihypertensive medications reduces cardiovascular risk in CKD. J Am Soc Nephrol 2011;22:2313-2321
14. Wang C, Zhang J, Liu X: Effect of valsartan with bedtime dosing on chronic kidney disease patients with nondipping blood pressure pattern. J Clin Hypertens (Greenwich) 2013;15:48-54
15. Li X: Clinical Observation of Benazepril with suitalbe time on the progression of chronic renal failure. Hubei Universtity of Chinese Medicine, Wuhan, Hubei, China, 2010
16. Xiao X, Hu W: Effect of Irbesartan with different time on blood pressure in patients with renal hypertension. Med J West China 2010;22: 2212-213
17. Gao Y, Yang S, Yan H, Wang R: Effect of losartan potassium/hydrochlorothiazide therapy with different time on blood pressure in patients with renal hypertension. Clin Focus 2008;23:810-811
18. Portaluppi F, Vergnani L, Manfredini R: Time-dependent effect of isradipine on the nocturnal hypertension in chronic renal failure. Am J Hypertens 1995;8:719-726
19. Crespo JJ, Pineiro L, Otero A, Castineira C, Rios MT, Regueiro A, Mojon A, Lorenzo S, Ayala DE, Hermida RC: Administration-time-dependent effects of hypertension treatment on ambulatory blood pressure in patients with chronic kidney disease. Chronobiol Int 2013;30:159-175
20. Hermida RC, Ayala DE, Mojoiàn A, Fernaiàndez JR: Use of ? 1 antihypertensive drug at bedtime reduced CV events more than use of all drugs in the morning in CKD. J Am Soc Nephrol 2011;22:2313-21
21. Minutolo R, Gabbai FB, Borrelli S, Scigliano R, Trucillo P, Baldanza D, Laurino S, Mascia S, Conte G, De Nicola L: Changing the timing of antihypertensive therapy to reduce nocturnal blood pressure in CKD: An 8-week uncontrolled trial. Am J Kidney Dis 2007;50:908-917
22. Rahman M, Greene T, Phillips RA, Agodoa LY, Bakris GL, Charleston J, Contreras G, Gabbai F, Hiremath L, Jamerson K, Kendrick C, Kusek JW, Lash JP, Lea J, Miller ER, 3rd, Rostand S, Toto R, Wang X, Wright JT, Jr., Appel LJ: A trial of 2 strategies to reduce nocturnal blood pressure in blacks with chronic kidney disease. Hypertension 2013;61:82-88
23. Wouden EA, Vogt L, Henning RH, Navis GJ, Zeeuw D, Hemmelder MH: Changing the trandolapril dosage regimen does not affect the proteinuria-lowering effect of ace inhibition in non-diabetic renal disease; Wetenschappelijk Platform 2009:3:156-159
24. He Z: Analysis of Chronotherapy in elderly hypertension of early renal damage. Chin Commun Doctors 2009;11:12
25. Braun LA, Sood V, Hogue S: High burden and unmet patient needs in chronic kidney disease. Int J Nephrol Renovasc Dis 2012;5:151-163
26. Zhang L, Wang F, Wang L: Prevalence of chronic kidney disease in china: A cross-sectional survey. Lancet 2012;379:815-822
27. Sumaili EK, Cohen EP, Zinga CV: High prevalence of undiagnosed chronic kidney disease among at-risk population in kinshasa, the democratic republic of Congo. BMC Nephrology 2009;10:18
28. Tedla FM, Brar A, Browne R: Hypertension in chronic kidney disease: Navigating the evidence. Int J Hypertens 2011;2011:132405
29. Kuang Z: Early Risk Assessment and Differences of Curative Effect in Hypertensive Patients with Renal Damage. Central South University, Changsha, Hunan, China, 2014
30. Pogue V, Rahman M, Lipkowitz M: Disparate estimates of hypertension control from ambulatory and clinic blood pressure measurements in hypertensive kidney disease. Hypertension 2009;53:20-27
31. Mojón A, Ayala DE, Piñeiro L: Comparison of ambulatory blood pressure parameters of hypertensive patients with and without chronic kidney disease. Chronobiol Int 2013;30:145-158
32. Drawz PE, Rosenthal N, Babineau DC: Nighttime hospital blood pressure-A predictor of death, ESRD, and decline in GFR. Ren Fail 2010;32:1036-1043
33. Agarwal R: Ambulatory blood pressure and cardiovascular events in chronic kidney disease. Semin Nephrol 2007;27:538-543
34. Agarwal R: Ambulatory blood pressure monitoring trumps estimated glomerular filtration rate in predicting cardiovascular risk in low-risk populations. Hypertension 2013;61:14-15
35. Agarwal R, Andersen MJ: Blood pressure recordings within and outside the clinic and cardiovascular events in chronic kidney disease. Am J Nephrol 2006;26:503-510
36. Cha RH, Kim S, Ae Yoon S, Ryu DR, Eun Oh J, Han SY, Young Lee E, Ki Kim D, Kim YS: Association between blood pressure and target organ damage in patients with chronic kidney disease and hypertension: Results of the APrODiTe study. Hypertens Res 2014;37:172-178
37. Hermida RC, Ayala DE, Mojon A, Fernandez JR: Decreasing sleep-time blood pressure determined by ambulatory monitoring reduces cardiovascular risk. J Am Coll Cardiol 2011;58:1165-1173
38. Redon J: The importance of 24-hour ambulatory blood pressure monitoring in patients at risk of cardiovascular events. High Blood Press Cardiovasc Prev 2013;20:13-18
39. Gabbai FB, Rahman M, Hu B, Appel LJ, Charleston J, Contreras G, Faulkner ML, Hiremath L, Jamerson KA, Lea JP, Lipkowitz MS, Pogue VA, Rostand SG, Smogorzewski MJ, Wright JT, Greene T, Gassman J, Wang X, Phillips RA, African American Study of Kidney D, Hypertension Study G: Relationship between ambulatory BP and clinical outcomes in patients with hypertensive CKD. Clin J Am Soc Nephrol 2012;7:1770-1776
40. Minutolo R, Agarwal R, Borrelli S, Chiodini P, Bellizzi V, Nappi F, Cianciaruso B, Zamboli P, Conte G, Gabbai FB, De Nicola L: Prognostic role of ambulatory blood pressure measurement in patients with nondialysis chronic kidney disease. Arch Intern Med 2011;171:1090-1098
41. Fan HQ, Li Y, Thijs L, Hansen TW, Boggia J, Kikuya M, Bjorklund-Bodegard K, Richart T, Ohkubo T, Jeppesen J, Torp-Pedersen C, Dolan E, Kuznetsova T, Stolarz-Skrzypek K, Tikhonoff V, Malyutina S, Casiglia E, Nikitin Y, Lind L, Sandoya E, Kawecka-Jaszcz K, Imai Y, Ibsen H, O'Brien E, Wang J, Staessen JA: Prognostic value of isolated nocturnal hypertension on ambulatory measurement in 8711 individuals from 10 populations. J Hypertens 2010;28:2036-2045
42. Hermida RC, Ayala DE, Fernández RJ, Mojón A: Sleep-time blood pressure: Prognostic value and relevance as a therapeutic target for cardiovascular risk reduction. Chronobiol Int 2013;30:68-86
43. Firsova OBD: Circadian regulation of renal function and potential role in hypertension. Curr Opin Nephrol Hypertens 2013;22:439-444
44. Waeber B, Burnier M, Brunner HR: Compliance with antihypertensive therapy. Clin Exp Hypertens 1999;21:973-985
45. Hermida RC, Ayala DE, Chayan L, Mojon A, Fernandez JR: Administration-time-dependent effects of olmesartan on the ambulatory blood pressure of essential hypertension patients. Chronobiol Int 2009;26:61-79
46. Hermida RC, Ayala DE, Fontao MJ, Mojon A, Alonso I, Fernandez JR: Administration-time-dependent effects of spirapril on ambulatory blood pressure in uncomplicated essential hypertension. Chronobiol Int 2010;27:560-574
47. Hermida RC, Calvo C, Ayala DE: Administration time-dependent effects of valsartan on ambulatory blood pressure in elderly hypertensive subjects. Chronobiol Int 2005;22:755-776
48. Zhao P, Xu P, Wan C, Wang Z: Evening versus morning dosing regimen drug therapy for hypertension (review). Cochrane Database Syst Rev 2011;10:1-65